# Changes in Health and Functional Status in Patients With Chronic Obstructive Pulmonary Disease During Therapy With Spiolto® Respimat® (AERIAL®)

> **NCT03165045** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 1351 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Spiolto® Respimat®

## Key facts

- **NCT ID:** NCT03165045
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-26
- **Primary completion:** 2019-02-04
- **Final completion:** 2019-03-24
- **Target enrollment:** 1351 (ACTUAL)
- **Last updated:** 2020-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03165045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03165045, "Changes in Health and Functional Status in Patients With Chronic Obstructive Pulmonary Disease During Therapy With Spiolto® Respimat® (AERIAL®)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03165045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*